|
现在注册,加入深空
您需要 登录 才可以下载或查看,没有帐号?加入深空
x
In an Asian phase II III trial ATTRACTION 4 reported in The Lancet Oncology, Yoon Koo Kang, MD, and colleagues found that the addition of nivolumab to oxaliplatin based chemotherapy improved progression free survival but not overall survival as first line treatment of HER2 negative, unresectable, <a href=http://cialis.lat/discover-the-best-prices-for-cialis>buy cheap cialis online</a> |
|